BGIM
SRDX

Boussard & Gavaudan Investment Management’s Surmodics SRDX Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-64,245
Closed -$1.89M – 90
2025
Q2 		$1.89M Sell
64,245
-24,402
-28% -$703K 0.24% 44
2025
Q1 		$2.74M Sell
88,647
-9,728
-10% -$328K 0.43% 41
2024
Q4 		$3.9M Buy
+98,375
New +$3.83M 0.33% 54

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boussard & Gavaudan Investment Management's SRDX Position: Q3 2025 in Review

Boussard & Gavaudan Investment Management sold out of Surmodics (SRDX) in Q3 2025, closing a stake of 64,245 shares — an estimated $1.89M sold.

Boussard & Gavaudan Investment Management first reported a position in SRDX in Q4 2024 and held it in 3 quarters. The position peaked at $3.9M in Q4 2024. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2025.

  • Boussard & Gavaudan Investment Management reported no remaining Surmodics position as of Q3 2025 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 64,245 Surmodics shares in Q3 2025, an estimated $1.89M.
  • Boussard & Gavaudan Investment Management first reported a position in Surmodics in Q4 2024 and held it in 3 quarters.
  • Boussard & Gavaudan Investment Management's Surmodics position peaked at $3.9M in Q4 2024.
  • 146 funds tracked by Wall St. Rank held Surmodics as of Q3 2025.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.